Vita Nova
Vita Nova: an adaptive ICT service for cardiovascular and metabolic risks reduction in premenopausal and menopausal women
(April 2016 / October 2018)
- Programme: FAR-FAS 2014 Regione Toscana
- Coordinator: Signo Motus
- Consortium: 5 partners (IT)
Abstract
Menopause is a physiological condition that affects all women. Its consequence is a low level of estrogens that often involves health problems both in the short and long period with a significant impact on the whole socio-sanitary system. Menopause itself is not a disease, however there is, for menopausal women, an increased risk of developing chronic diseases and co-morbidity, and consequently a reduction of their quality of life. Vita Nova aims at implementing a customized and adaptive prototype for women in pre-menopausal and menopausal able to increase their awareness about the condition they are experiencing and the consequences of any unhealthy behaviour. The App will record all the data related to the lifestyle and the behaviours of the user in order to provide them with the most appropriate support capable to lead them to change. The application will be highly customizable and adaptable to the preferences, personality and resources of women, placing them at the centre of a large heterogeneous stakeholder ecosystem that also includes health and wellness providers.
Vita Nova aims to be a low-cost tool, not necessarily included in public health systems or subject to public reimbursement schemes. Its business model will be based on a direct
“customer-supplier” relationship without the need to integrate its offer in the complexity of the public health system. However there will be the possibility to make agreements
with the public health system or private insurances. In addition, the service model can be adapted to other chronic conditions or pathologies or co-morbidity situations.
The impact of the system will be assessed in relation to:
- The improvement of the Quality of Life in pre-menopausal and menopausal women;
- A better management of the health of women;
- The reduction of the risk of developing metabolic and cardiovascular diseases.
